Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/182720
Title: Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
Author: Guasp, Mar
Landa, Jon
Martínez Hernández, Eugenia
Sabater, Lidia
Iizuka, Takahiro
Simabukuro, Mateus
Nakamura, Masataka
Kinoshita, Makoto
Kaida, Kenichi
Bruna, Jordi
Kapetanovic, Solange
Sánchez, Pedro
Ruiz García, Raquel
Naranjo, Laura
Planagumà, Jesús
Muñoz Lopetegi, Amaia
Bataller, Luis
Saiz, Albert
Dalmau Obrador, Josep
Graus Ribas, Francesc
Kurihara, Masanori
Keywords: Encefalitis
Estudi de casos
Immunologia
Encephalitis
Case studies
Immunology
Issue Date: 23-Jul-2021
Abstract: To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma.A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques.Patients' median age was 52 years (range: 23-88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti-collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABAAR, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABAAR encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis).AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABAAR encephalitis was the most frequent AE and occurred more frequently in Japanese patients.
Note: Reproducció del document publicat a: https://doi.org/10.1212/nxi.0000000000001053
It is part of: Neurology-Neuroimmunology & Neuroinflammation, 2021, vol. 8, num. 5, p. e1053
URI: http://hdl.handle.net/2445/182720
Related resource: https://doi.org/10.1212/nxi.0000000000001053
ISSN: 2332-7812
Appears in Collections:Articles publicats en revistes (Institut de Neurociències (UBNeuro))
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
12474_9274278_thymomae1053.full.pdf493.55 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons